A Role for Estrogen Receptor alpha36 in Cancer Progression

ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway

(2020) Guangliang Li et al.   Cancer Management and Research

Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer

(2019) Angela Maselli et al.   Cells

Origin and initiation mechanisms of neuroblastoma

(2018) Shoma Tsubota et al.   CELL AND TISSUE RESEARCH

Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells

(2018) Qiang Wang et al.   CELL RESEARCH

ERα36 gene silencing promotes tau protein phosphorylation, inhibits cell proliferation, and induces apoptosis in human neuroblastoma SH-SY5Y cells

(2018) Hong-Bin Wang et al.   FASEB JOURNAL

Crosstalk between ERα and Receptor Tyrosine Kinase Signalling and Implications for the Development of Anti-Endocrine Resistance

(2018) Rugaia Montaser et al.   Cancers

Estrogen receptor variant ER-α36 promotes tamoxifen agonist activity in glioblastoma cells

(2018) Chao Qu et al.   CANCER SCIENCE

Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer

(2018) Melissa A. Maczis et al.   JOURNAL OF LIPID RESEARCH

G protein-coupled estrogen receptor 1 (GPER1)/GPR30 increases ERK1/2 activity through PDZ motif-dependent and -independent mechanisms

(2017) Ernesto Gonzalez de Valdivia et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas

(2017) Yu-Jie Dai et al.   Scientific Reports

Alternative splicing of estrogen receptor alpha in hepatocellular carcinoma

(2016) Jian Zhang et al.   BMC CANCER

Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors

(2016) Ellis R. Levin et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer

(2016) S Omarjee et al.   ONCOGENE

ER-α36, a novel variant of ERα, is involved in the regulation of Tamoxifen-sensitivity of glioblastoma cells

(2016) Yang Liu et al.   STEROIDS

Estrogen receptor α enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner

(2015) Peng Cao et al.   BMC CANCER

ERα36 – Another piece of the estrogen puzzle

(2015) Kamil Sołtysik et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Modulatory role of 17β-estradiol in the tumor microenvironment of thyroid cancer

(2015) Sithul Hima et al.   IUBMB LIFE

High ERα36 Expression Level and Membrane Location Predict Poor Prognosis in Renal Cell Carcinoma

(2015) Qiang Wang et al.   MEDICINE

Estrogen receptor alpha-36 (ER-α36): A new player in human breast cancer

(2015) Zhao-Yi Wang et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation

(2015) Angela Maselli et al.   OncoImmunology

Role of estrogen in hepatocellular carcinoma: is inflammation the key?

(2014) Liang Shi et al.   Journal of Translational Medicine

ER-α36: a novel biomarker and potential therapeutic target in breast cancer

(2014) Lisong Teng et al.   OncoTargets and Therapy

Increased Expression of Estrogen Receptor a-36 by Breast Cancer Oncogene IKKe Promotes Growth of ER-Negative Breast Cancer Cells

(2013) Qihong Li et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Expression of ER-a36, a Novel Variant of Estrogen Receptor in Endometrial Carcinoma and Its Clinical Significance

(2013) Lifang Sun et al.   GYNECOLOGIC AND OBSTETRIC INVESTIGATION

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

(2013)   LANCET

Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells

(2013) Guangliang Li et al.   Molecular Oncology

17Beta-Estradiol Promotes Aggressive Laryngeal Cancer Through Membrane-Associated Estrogen Receptor-Alpha 36

(2013) Nofrat Schwartz et al.   Hormones & Cancer

Membrane Estrogen Signaling Enhances Tumorigenesis and Metastatic Potential of Breast Cancer Cells via Estrogen Receptor-α36 (ERα36)

(2012) Reyhaan A. Chaudhri et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Estrogen Receptor-Alpha 36 Mediates Mitogenic Antiestrogen Signaling in ER-Negative Breast Cancer Cells

(2012) XinTian Zhang et al.   PLoS One

ER-α36, a novel variant of estrogen receptor α, is involved in EGFR-related carcinogenesis in endometrial cancer

(2011) Bin-Bin Tu et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Factors connected with the female sex seem to play an important role in differentiated thyroid cancer

(2011) Elwira Przybylik-Mazurek et al.   GYNECOLOGICAL ENDOCRINOLOGY

Expression of Wild-Type and Variant Estrogen Receptor Alpha in Liver Carcinogenesis and Tumor Progression

(2011) Vitale Miceli et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

Expression of ERα36 in gastric cancer samples and their matched normal tissues

(2011) JIANJUN WANG et al.   Oncology Letters

Mechanisms of Endocrine Resistance in Breast Cancer

(2010) C. Kent Osborne et al.   Annual Review of Medicine

A variant of estrogen receptor-α, ER-α36 is expressed in human gastric cancer and is highly correlated with lymph node metastasis

(2010) Liu   ONCOLOGY REPORTS

ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways

(2010) Sheng-Li Lin et al.   PLoS One

ER-α36, a Novel Variant of ER-α, Mediates Estrogen-Stimulated Proliferation of Endometrial Carcinoma Cells via the PKCδ/ERK Pathway

(2010) Jing-Shan Tong et al.   PLoS One

MYCN-regulated microRNAs repress estrogen receptor-  (ESR1) expression and neuronal differentiation in human neuroblastoma

(2010) J. Loven et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Sex Disparities in Cancer Incidence by Period and Age

(2009) M. B. Cook et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Resistance to chemotherapy and hormone therapy in endometrial cancer

(2009) Parvesh Chaudhry et al.   ENDOCRINE-RELATED CANCER

Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer

(2009) Liang Shi et al.   JOURNAL OF CLINICAL ONCOLOGY

Estradiol Regulates Expression of Estrogen Receptor ERα46 in Human Macrophages

(2009) Amy J. Murphy et al.   PLoS One

Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer

(2008) Neal D. Freedman et al.   CARCINOGENESIS

Polycystic Ovary Syndrome and Endometrial Cancer

(2008) Ramesan Navaratnarajah et al.   SEMINARS IN REPRODUCTIVE MEDICINE

Membrane association of estrogen receptor α and β influences 17β-estradiol-mediated cancer cell proliferation

(2008) M MARINO et al.   STEROIDS